Radiotheranostics in oncology: Current challenges and emerging opportunities Review
| Authors: | Bodei, L.; Herrmann, K.; Schöder, H.; Scott, A. M.; Lewis, J. S. |
| Review Title: | Radiotheranostics in oncology: Current challenges and emerging opportunities |
| Abstract: | Structural imaging remains an essential component of diagnosis, staging and response assessment in patients with cancer; however, as clinicians increasingly seek to noninvasively investigate tumour phenotypes and evaluate functional and molecular responses to therapy, theranostics — the combination of diagnostic imaging with targeted therapy — is becoming more widely implemented. The field of radiotheranostics, which is the focus of this Review, combines molecular imaging (primarily PET and SPECT) with targeted radionuclide therapy, which involves the use of small molecules, peptides and/or antibodies as carriers for therapeutic radionuclides, typically those emitting α-, β- or auger-radiation. The exponential, global expansion of radiotheranostics in oncology stems from its potential to target and eliminate tumour cells with minimal adverse effects, owing to a mechanism of action that differs distinctly from that of most other systemic therapies. Currently, an enormous opportunity exists to expand the number of patients who can benefit from this technology, to address the urgent needs of many thousands of patients across the world. In this Review, we describe the clinical experience with established radiotheranostics as well as novel areas of research and various barriers to progress. © 2022, Springer Nature Limited. |
| Keywords: | adult; review; human |
| Journal Title: | Nature Reviews Clinical Oncology |
| Volume: | 19 |
| Issue: | 8 |
| ISSN: | 1759-4774 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2022-08-01 |
| Start Page: | 534 |
| End Page: | 550 |
| Language: | English |
| DOI: | 10.1038/s41571-022-00652-y |
| PUBMED: | 35725926 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Review -- Export Date: 1 August 2022 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work